Smart watch applications in atrial fibrillation detection: Current state and future directions
Rahul Vyas MD
Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
Search for more papers by this authorShubhika Jain MBBS
Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
Search for more papers by this authorAnuj Thakre MD
Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
Search for more papers by this authorSahith Reddy Thotamgari MD
Division of Cardiology, Department of Medicine, Louisiana State University Health Sciences Center, Ochsner-LSU Health, Shreveport, Louisiana, USA
Search for more papers by this authorSameer Raina MD
Division of Cardiovascular Medicine, Stanford Cardiovascular Institute, Stanford University, Stanford, California, USA
Search for more papers by this authorVijaywant Brar MD
Division of Cardiology, Department of Medicine, Louisiana State University Health Sciences Center, Ochsner-LSU Health, Shreveport, Louisiana, USA
Search for more papers by this authorPartho Sengupta MD
Division of Cardiovascular Diseases, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Search for more papers by this authorCorresponding Author
Pratik Agrawal MD
Division of Cardiology, Department of Medicine, Louisiana State University Health Sciences Center, Ochsner-LSU Health, Shreveport, Louisiana, USA
Correspondence Pratik Agrawal, MD, Division of Cardiology, Department of Internal Medicine, Louisiana State University, 1501 Kings Hwy, Shreveport, LA 71103, USA.
Email: [email protected]
Search for more papers by this authorRahul Vyas MD
Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
Search for more papers by this authorShubhika Jain MBBS
Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
Search for more papers by this authorAnuj Thakre MD
Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
Search for more papers by this authorSahith Reddy Thotamgari MD
Division of Cardiology, Department of Medicine, Louisiana State University Health Sciences Center, Ochsner-LSU Health, Shreveport, Louisiana, USA
Search for more papers by this authorSameer Raina MD
Division of Cardiovascular Medicine, Stanford Cardiovascular Institute, Stanford University, Stanford, California, USA
Search for more papers by this authorVijaywant Brar MD
Division of Cardiology, Department of Medicine, Louisiana State University Health Sciences Center, Ochsner-LSU Health, Shreveport, Louisiana, USA
Search for more papers by this authorPartho Sengupta MD
Division of Cardiovascular Diseases, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Search for more papers by this authorCorresponding Author
Pratik Agrawal MD
Division of Cardiology, Department of Medicine, Louisiana State University Health Sciences Center, Ochsner-LSU Health, Shreveport, Louisiana, USA
Correspondence Pratik Agrawal, MD, Division of Cardiology, Department of Internal Medicine, Louisiana State University, 1501 Kings Hwy, Shreveport, LA 71103, USA.
Email: [email protected]
Search for more papers by this authorDisclosures: None.
Abstract
Introduction
Atrial fibrillation (Afib) is a prevalent chronic arrhythmia associated with severe complications, including stroke, heart failure, and increased mortality. This review explores the use of smartwatches for Afib detection, addressing the limitations of current monitoring methods and emphasizing the potential of wearable technology in revolutionizing healthcare.
Results/Observation
Current Afib detection methods, such as electrocardiography, have limitations in sensitivity and specificity. Smartwatches with advanced sensors offer continuous monitoring, improving the chances of detecting asymptomatic and paroxysmal Afib. The review meticulously examines major clinical trials studying Afib detection using smartwatches, including the landmark Apple Heart Study and ongoing trials such as the Heart Watch, Heartline, and Fitbit Heart Study. Detailed summaries of participant numbers, smartwatch devices used, and key findings are presented. It also comments on the cost-effectiveness and scalability of smartwatch-based screening, highlighting the potential to reduce healthcare costs and improve patient outcomes.
Conclusion/Relevance
The integration of wearable technology into healthcare can lead to earlier diagnosis, improved patient engagement, and enhanced cardiac health monitoring. Despite ethical considerations and disparities, the potential benefits outweigh the challenges. This review calls for increased awareness, collaboration with insurance companies, and ongoing research efforts to optimize smartwatch accuracy and encourage widespread adoption of Afib detection. With insights from major trials, this review serves as a comprehensive reference for healthcare professionals and policymakers, guiding future strategies in the early diagnosis and management of atrial fibrillation.
CONFLICT OF INTEREST STATEMENT
The authors declare no conflict of interest.
Open Research
DATA AVAILABILITY STATEMENT
Data sharing is not applicable to this article as no data sets were generated or analyzed during the current study.
REFERENCES
- 1Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation. 1998; 98(10): 946-952.
- 2Feinberg WM. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995; 155(5): 469-473.
- 3Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ Res. 2017; 120(9): 1501-1517.
- 4Rodriguez CJ, Soliman EZ, Alonso A, et al. Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the multi-ethnic study of atherosclerosis. Ann Epidemiol. 2015; 25(2): 71-76.
- 5Violi F, Soliman EZ, Pignatelli P, Pastori D. Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc. 2016; 5(5):e003347. doi:10.1161/JAHA.116.003347
- 6Börschel CS, Schnabel RB. The imminent epidemic of atrial fibrillation and its concomitant diseases—Myocardial infarction and heart failure—A cause for concern. Int J Cardiol. 2019; 287: 162-173.
- 7Dhingra LS, Aminorroaya A, Oikonomou EK, et al. Use of wearable devices in individuals with or at risk for cardiovascular disease in the US, 2019 to 2020. JAMA Network Open. 2023; 6(6):e2316634.
- 8 Straits Research. Smartwatch market. Accessed January 7, 2024. https://straitsresearch.com/report/smartwatch-market
- 9Seshadri DR, Bittel B, Browsky D, et al. Accuracy of Apple watch for detection of atrial fibrillation. Circulation. 2020; 141(8): 702-703.
- 10Wasserlauf J, Vogel K, Whisler C, et al. Accuracy of the Apple watch for detection of AF: a multicenter experience. J Cardiovasc Electrophysiol. 2023; 34(5): 1103-1107.
- 11Nemati S, Ghassemi MM, Ambai V, et al. Monitoring and detecting atrial fibrillation using wearable technology. Conf Proc IEEE Eng Med Biol Soc. 2016, 2016: 3394-3397.
10.1109/EMBC.2016.7591456 Google Scholar
- 12Lubitz SA, Faranesh AZ, Selvaggi C, et al. Detection of atrial fibrillation in a large population using wearable devices: the Fitbit heart study. Circulation. 2022; 146(19): 1415-1424.
- 13Bumgarner JM, Lambert CT, Hussein AA, et al. Smartwatch algorithm for automated detection of atrial fibrillation. J Am Coll Cardiol. 2018; 71(21): 2381-2388.
- 14January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014; 64(21):e1–76.
- 15Galli A, Ambrosini F, Lombardi F. Holter monitoring and loop recorders: from research to clinical practice. Arrhythm Electrophysiol Rev. 2016; 5(2): 136-143.
- 16Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893-2962.
- 17Mairesse GH, Moran P, Van Gelder IC, et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). Europace. 2017; 19(10): 1589-1623.
- 18Hobbs F, Fitzmaurice D, Mant J, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. the SAFE study. Health Technol Assess. 2005; 9(40): 1-74.
- 19Sudlow M, Rodgers H, Kenny RA, Thomson R. Identification of patients with atrial fibrillation in general practice: a study of screening methods. BMJ. 1998; 317(7154): 327-328.
- 20Morgan S, Mant D. Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. Br J General Pract. 2002; 52(478): 373-374.
- 21Khurshid S, Healey JS, McIntyre WF, Lubitz SA. Population-based screening for atrial fibrillation. Circ Res. 2020; 127(1): 143-154.
- 22Srinivasulu A, Sriraam N. An engineering perspective of external cardiac loop recorder: a systematic review. J Med Eng. 2016; 2016:6931347.
- 23Zimetbaum P, Goldman A. Ambulatory arrhythmia monitoring: choosing the right device. Circulation. 2010; 122(16): 1629-1636.
- 24Mittal S, Movsowitz C, Steinberg JS. Ambulatory external electrocardiographic monitoring. J Am Coll Cardiol. 2011; 58(17): 1741-1749.
- 25Silveira I, Sousa MJ, Antunes N, et al. Efficacy and safety of implantable loop recorder: experience of a center. J Atr Fibrillation. 2016; 9(2): 1425.
- 26Perez MV, Mahaffey KW, Hedlin H, et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med. 2019; 381(20): 1909-1917.
- 27Dörr M, Nohturfft V, Brasier N, et al. The WATCH AF trial: SmartWATCHes for detection of atrial fibrillation. JACC Clin Electrophysiol. 2019; 5(2): 199-208.
- 28Tison GH, Sanchez JM, Ballinger B, et al. Passive detection of atrial fibrillation using a commercially available smartwatch. JAMA Cardiol. 2018; 3(5): 409-416.
- 29Guo Y, Zhang H, Lip GYH. Consumer-Led screening for atrial fibrillation. JACC. 2022; 2(6): 737-746.
- 30Spertus J, Dorian P, Bubien R, et al. Development and validation of the atrial fibrillation effect on QualiTy-of-Life (AFEQT) questionnaire in patients with atrial fibrillation. Circul Arrhyth Electrophysiol. 2011; 4(1): 15-25.
- 31Dhruva SS, Shah ND, Vemulapalli S, et al. Heart watch study: protocol for a pragmatic randomised controlled trial. BMJ Open. 2021; 11(12):e054550.
- 32Gibson CM, Steinhubl S, Lakkireddy D, et al. Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the heartline study. Am Heart J. 2023; 259: 30-41.
- 33Lubitz SA, Faranesh AZ, Atlas SJ, et al. Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: the Fitbit heart study. Am Heart J. 2021; 238: 16-26.
- 34Prasitlumkum N, Cheungpasitporn W, Chokesuwattanaskul A, et al. Diagnostic accuracy of smart gadgets/wearable devices in detecting atrial fibrillation: a systematic review and meta-analysis. Arch Cardiovasc Dis. 2021; 114(1): 4-16.
- 35Svennberg E, Engdahl J, Al-Khalili F, Friberg L. Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation. 2015. https://www.ahajournals.org/doi/abs/10.1161/circulationaha.114.014343
- 36Aronsson M, Svennberg E, Rosenqvist M, et al. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace. 2015; 17(7): 1023-1029.
- 37Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm. 2006; 3(12): 1445-1452.
- 38Turakhia MP, Hoang DD, Zimetbaum P, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013; 112(4): 520-524.
- 39Taggar JS, Coleman T, Lewis S, Heneghan C, Jones M. Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: a systematic review and meta-analysis. Eur J Prevent Cardiol. 2016; 23(12): 1330-1338.
- 40Belani S, Wahood W, Hardigan P, Placzek AN, Ely S. Accuracy of detecting atrial fibrillation: a systematic review and meta-analysis of Wrist-Worn wearable technology. Cureus. 2021; 13(12):e20362.
- 41Babar F, Cheema AM, Ahmad Z, et al. Sensitivity and specificity of wearables for atrial fibrillation in elderly populations: a systematic review. Curr Cardiol Rep. 2023; 25(7): 761-779.
- 42Bentov I, Reed MJ. The effect of aging on the cutaneous microvasculature. Microvasc Res. 2015; 100: 25-31.
- 43Kohn JC, Lampi MC, Reinhart-King CA. Age-related vascular stiffening: causes and consequences. Front Genet. 2015; 6: 112.
- 44 Apple Support [Internet]. Take an ECG with the ECG app on Apple watch. 2022. Accessed July 13, 2023. https://support.apple.com/en-us/HT208955
- 45 Apple Support [Internet]. Get the most accurate measurements using your Apple Watch. 2022. Accessed July 13, 2023. https://support.apple.com/en-gb/HT207941
- 46Nazarian S, Lam K, Darzi A, Ashrafian H. Diagnostic accuracy of smartwatches for the detection of cardiac arrhythmia: systematic review and meta-analysis. J Med Internet Res. 2021; 23(8):e28974.
- 47Dickson EL, Ding EY, Saczynski JS, et al. Smartwatch monitoring for atrial fibrillation after stroke—the pulsewatch study: protocol for a multiphase randomized controlled trial. Cardiovasc Digit Health J. 2021; 2(4): 231-241.
- 48Chen W, Khurshid S, Singer DE, et al. Cost-effectiveness of screening for atrial fibrillation using wearable devices. JAMA Health Forum. 2022; 3(8):e222419.
- 49Predel C, Steger F. Ethical challenges with smartwatch-based screening for atrial fibrillation: putting users at risk for marketing purposes? Front Cardiovasc Med. 2021; 7:615927.
- 50English KM, Channer KS. Managing atrial fibrillation in elderly people. BMJ. 1999; 318(7191): 1088-1089.
- 51Sharon T. The googlization of health research: from disruptive innovation to disruptive ethics. Personal Med. 2016; 13(6): 563-574.
- 52Mandrola J, Foy A, Naccarelli G. Screening for atrial fibrillation comes with many snags. JAMA Int Med. 2018; 178(10): 1296-1298.
- 53Marcus GM. The Apple watch can detect atrial fibrillation: so what now? Nat Rev Cardiol. 2020; 17(3): 135-136.
- 54Atrial fibrillation: Screening [Internet]. US Preventive Services Taskforce; 2022. Accessed August 25, 2023. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/atrial-fibrillation-screening